Lisa C. Morton

827 total citations
9 papers, 414 citations indexed

About

Lisa C. Morton is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Infectious Diseases. According to data from OpenAlex, Lisa C. Morton has authored 9 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Pulmonary and Respiratory Medicine and 1 paper in Infectious Diseases. Recurrent topics in Lisa C. Morton's work include Neonatal Respiratory Health Research (3 papers), Cystic Fibrosis Research Advances (2 papers) and Cancer-related gene regulation (2 papers). Lisa C. Morton is often cited by papers focused on Neonatal Respiratory Health Research (3 papers), Cystic Fibrosis Research Advances (2 papers) and Cancer-related gene regulation (2 papers). Lisa C. Morton collaborates with scholars based in United States, Sweden and Italy. Lisa C. Morton's co-authors include Brad A. Amendt, Carol J. Cox, Herbert M. Espinoza, Tord Hjalt, Elena V. Semina, Wanda K. O’Neal, Youngsook Lee, Camille Ehré, Hong Dang and Cameron B. Morrison and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Lisa C. Morton

8 papers receiving 409 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lisa C. Morton United States 8 246 93 52 50 35 9 414
Shihoko Sata Japan 5 226 0.9× 44 0.5× 26 0.5× 68 1.4× 24 0.7× 7 384
Frans Schutgens Netherlands 7 286 1.2× 73 0.8× 32 0.6× 41 0.8× 38 1.1× 10 584
Richard Van Rheeden United States 9 265 1.1× 50 0.5× 83 1.6× 120 2.4× 11 0.3× 10 398
Meng Wu United States 10 195 0.8× 25 0.3× 28 0.5× 55 1.1× 11 0.3× 21 313
Yutong Xing China 15 174 0.7× 77 0.8× 16 0.3× 30 0.6× 13 0.4× 27 446
Marie-Hélène Gaumond Canada 9 217 0.9× 28 0.3× 52 1.0× 155 3.1× 16 0.5× 12 479
Ella G. Frolova United States 7 462 1.9× 31 0.3× 32 0.6× 60 1.2× 14 0.4× 9 640
Shinji Yano Japan 13 192 0.8× 67 0.7× 45 0.9× 12 0.2× 9 0.3× 27 429
Venkateshwar Mutyam United States 10 333 1.4× 300 3.2× 35 0.7× 67 1.3× 7 0.2× 14 583

Countries citing papers authored by Lisa C. Morton

Since Specialization
Citations

This map shows the geographic impact of Lisa C. Morton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa C. Morton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa C. Morton more than expected).

Fields of papers citing papers by Lisa C. Morton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa C. Morton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa C. Morton. The network helps show where Lisa C. Morton may publish in the future.

Co-authorship network of co-authors of Lisa C. Morton

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa C. Morton. A scholar is included among the top collaborators of Lisa C. Morton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa C. Morton. Lisa C. Morton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Cawley, Adam, Z. Wiśniewski, Hong Dang, et al.. (2023). 201 SCGB3A2-positive distal airway secretory cells are a therapeutic target for CFTR function restoration. Journal of Cystic Fibrosis. 22. S105–S105. 1 indexed citations
2.
Morrison, Cameron B., Caitlin E. Edwards, Takanori Asakura, et al.. (2022). SARS-CoV-2 infection of airway cells causes intense viral and cell shedding, two spreading mechanisms affected by IL-13. Proceedings of the National Academy of Sciences. 119(16). e2119680119–e2119680119. 62 indexed citations
3.
Lee, Rhianna E., Lihua He, Emily Bulik-Sullivan, et al.. (2022). Small-molecule eRF3a degraders rescue CFTR nonsense mutations by promoting premature termination codon readthrough. Journal of Clinical Investigation. 132(18). 22 indexed citations
4.
Morrison, Cameron B., Matthew R. Markovetz, Nancy L. Quinney, et al.. (2021). Treatment of cystic fibrosis airway cells with CFTR modulators reverses aberrant mucus propertiesviahydration. European Respiratory Journal. 59(2). 2100185–2100185. 42 indexed citations
5.
Carpenter, Jerome, Yang Wang, Richa Gupta, et al.. (2021). Assembly and organization of the N-terminal region of mucin MUC5AC: Indications for structural and functional distinction from MUC5B. Proceedings of the National Academy of Sciences. 118(39). 45 indexed citations
6.
Heusden, Catharina van, Brian Button, Wayne H. Anderson, et al.. (2019). Inhibition of ATP hydrolysis restores airway surface liquid production in cystic fibrosis airway epithelia. American Journal of Physiology-Lung Cellular and Molecular Physiology. 318(2). L356–L365. 12 indexed citations
7.
Espinoza, Herbert M., Carol J. Cox, Lisa C. Morton, et al.. (2003). PITX2 Isoform-specific Regulation of Atrial Natriuretic Factor Expression. Journal of Biological Chemistry. 278(25). 22437–22445. 67 indexed citations
8.
Cox, Carol J., Herbert M. Espinoza, Lisa C. Morton, et al.. (2002). Differential Regulation of Gene Expression by PITX2 Isoforms. Journal of Biological Chemistry. 277(28). 25001–25010. 129 indexed citations
9.
Tuan, Tai‐Lan, David T. Cheung, Lingtao Wu, et al.. (1996). Engineering, Expression and Renaturation of Targeted TGF-Beta Fusion Proteins. Connective Tissue Research. 34(1). 1–9. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026